BIOATLA, INC. Investment Income, Interest
BIOATLA, INC. (BCAB) reported Investment Income, Interest of $16.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- BIOATLA, INC. investment income, interest for the quarter ending 2026-06-30 was $16.00K, a 93.13% decline year-over-year.
- BIOATLA, INC. investment income, interest for the quarter ending 2026-03-31 was $37.00K, a 90.75% decline year-over-year.
- BIOATLA, INC. investment income, interest for the quarter ending 2025-12-31 was $73.00K, a 86.82% decline year-over-year.
- BIOATLA, INC. investment income, interest for the quarter ending 2025-09-30 was $133.00K, a 80.78% decline year-over-year.
- BIOATLA, INC. investment income, interest for fiscal 2025 was $843.00K, a 74.98% decline from fiscal 2024.
- BIOATLA, INC. investment income, interest for fiscal 2024 was $3.37M, a 46.63% decline from fiscal 2023.
- BIOATLA, INC. investment income, interest for fiscal 2023 was $6.31M, a 283.01% increase from fiscal 2022.
- BIOATLA, INC. investment income, interest for fiscal 2022 was $1.65M, a 370.86% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-08-13 | $53.00K 10-Q · filed 2026-08-13 | $126.00K derived: sum of 3 quarters · filed 2026-08-13 | $259.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $37.00K 10-Q · filed 2026-05-15 | $110.00K derived: sum of 2 quarters · filed 2026-05-15 | $243.00K derived: sum of 3 quarters · filed 2026-05-15 | $476.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $206.00K derived: sum of 2 quarters · filed 2026-03-31 | $439.00K derived: sum of 3 quarters · filed 2026-08-13 | $843.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $133.00K 10-Q · filed 2025-11-13 | $366.00K derived: sum of 2 quarters · filed 2026-08-13 | $770.00K 10-Q · filed 2025-11-13 | $1.32M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $233.00K 10-Q · filed 2026-08-13 | $633.00K 10-Q · filed 2026-08-13 | $1.19M derived: sum of 3 quarters · filed 2026-08-13 | $1.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-15 | $954.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.65M derived: sum of 3 quarters · filed 2026-05-15 | $2.55M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $554.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.25M derived: sum of 2 quarters · filed 2026-03-31 | $2.15M derived: sum of 3 quarters · filed 2026-03-31 | $3.37M 10-K · filed 2026-03-31 |
| 2024-09-30 | $692.00K 10-Q · filed 2025-11-13 | $1.59M derived: sum of 2 quarters · filed 2025-11-13 | $2.81M 10-Q · filed 2025-11-13 | $4.45M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $900.00K 10-Q · filed 2025-08-07 | $2.12M 10-Q · filed 2025-08-07 | $3.76M derived: sum of 3 quarters · filed 2025-08-07 | $5.50M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-06 | $2.86M derived: sum of 2 quarters · filed 2025-05-06 | $4.59M derived: sum of 3 quarters · filed 2025-05-06 | $6.05M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $3.37M derived: sum of 2 quarters · filed 2025-03-28 | $4.83M derived: sum of 3 quarters · filed 2025-03-28 | $6.31M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.73M 10-Q · filed 2024-11-07 | $3.19M derived: sum of 2 quarters · filed 2024-11-07 | $4.67M 10-Q · filed 2024-11-07 | $5.72M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.46M 10-Q · filed 2024-08-08 | $2.94M 10-Q · filed 2024-08-08 | $3.99M derived: sum of 3 quarters · filed 2024-08-08 | $4.36M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.48M 10-Q · filed 2024-05-14 | $2.53M derived: sum of 2 quarters · filed 2024-05-14 | $2.90M derived: sum of 3 quarters · filed 2024-05-14 | $3.04M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $1.42M derived: sum of 2 quarters · filed 2024-03-26 | $1.56M derived: sum of 3 quarters · filed 2024-03-26 | $1.65M 10-K · filed 2024-03-26 |
| 2022-09-30 | $370.00K 10-Q · filed 2023-11-07 | $516.00K derived: sum of 2 quarters · filed 2023-11-07 | $601.00K 10-Q · filed 2023-11-07 | $697.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $146.00K 10-Q · filed 2023-08-01 | $231.00K 10-Q · filed 2023-08-01 | $327.00K derived: sum of 3 quarters · filed 2023-08-01 | $403.00K derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $85.00K 10-Q · filed 2023-05-11 | $181.00K derived: sum of 2 quarters · filed 2023-05-11 | $257.00K derived: sum of 3 quarters · filed 2023-05-11 | $337.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $172.00K derived: sum of 2 quarters · filed 2023-03-23 | $252.00K derived: sum of 3 quarters · filed 2023-03-23 | $350.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $76.00K 10-Q · filed 2022-11-04 | $156.00K derived: sum of 2 quarters · filed 2022-11-04 | $254.00K 10-Q · filed 2022-11-04 | $317.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $80.00K 10-Q · filed 2022-08-09 | $178.00K 10-Q · filed 2022-08-09 | $241.00K derived: sum of 3 quarters · filed 2022-08-09 | $272.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $98.00K 10-Q · filed 2022-05-05 | $161.00K derived: sum of 2 quarters · filed 2022-05-05 | $192.00K derived: sum of 3 quarters · filed 2022-05-05 | $193.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $94.00K derived: sum of 2 quarters · filed 2022-02-28 | $95.00K derived: sum of 3 quarters · filed 2022-02-28 | $100.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $31.00K 10-Q · filed 2021-11-15 | $32.00K derived: sum of 2 quarters · filed 2021-11-15 | $37.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $1.00K 10-Q · filed 2021-08-13 | $6.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $128.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |